Active Ingredient: THIOTEPA
Proprietary Name: THIOTEPA
Dosage Form; Route of Administration: POWDER; INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A214222
Product Number: 002
Approval Date: Jan 3, 2022
Applicant Holder Full Name: GLAND PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information